A new study uses data from humans and worms to generated new insights into the mutational causes of cancer. [A new study uses data from humans and worms to generated new insights into the mutational causes of cancer. [HeitiPaves

C. elegans Study Offers Insights into Cancer Mutation Origins in Humans

Researchers refine what they know about cancer by using C. elegans as a model system for studying DNA mismatch repair in greater detail
Biodesix said today that its VeriStrat proteomic blood test

Study Confirms Prognostic Value of Biodesix VeriStrat Test in NSCLC Patients

Test shown as significant predictor of outcomes independent of EGFR mutation status, treatment received, and other clinical variables

Genomics England Reports Positive First Phase of Cancer ctDNA Study

Genomics England said it has generated positive results from the first phase of a collaboration with Inivata and Thermo Fisher Scientific designed to study...
Myriad Genetics has received a final local coverage determination for its myPath Melanoma test from the Medicare Administrative Contractor Palmetto GBA MolDx. [Myriad Genetics]

Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test

23-gene test designed to help physicians offer a definitive diagnosis when a suspicious skin lesion is equivocal based upon histopathology
Artistic interpretation of an exosome carrying DNA/RNA from a cancer cell. [National Institutes of Health]

Exosome Protein Useful for Early Pancreatic Cancer Detection

Precision noninvasive screening tools are paramount to diagnostic medicine for the early detection of potentially life-threating diseases. Now, researchers at The University of Texas...
Sourse: NASA

OMICS in Space: NASA Video Seeks to Advance Personalized Medicine on Terra Firma

New video highlights NASA's twins study research.
Source: mirceax/Getty Images

Zika Biomarkers Could Lead to Prenatal Diagnostic

A panel of Zika virus positive biomarkers may lead to a better understanding of how the infection in pregnancy leads to fetal abnormalities
Source: © Photographee.eu/Fotolia

Thermo Fisher to Develop NGS-based CDx for Agios’ Cancer Candidate

Companion diagnostic for Agios' ivosidenib (AG-120) will be designed to identify IDH1 mutations in patients with cholangiocarcinoma.
Companies say their initial projects will entail developing new automation systems based on PCR and NGS technologies. [iStock/© Chagin]

Hitachi High-Tech, Qiagen Enter Molecular Testing Collaboration

Hitachi High-Technologies and Qiagen said today they have launched a long-term strategic collaboration to develop molecular testing tools. The value of the collaboration was...
Source: chrupka/Getty Images

FDA Approves Invivoscribe’s CDx for AML Drug Xospata

The LeukoStrat CDx FLT3 Mutation Assay had previously won approval in the U.S. and Europe for Novartis drug Rydapt
Scroll Up